Homeostatic Regulation of Lung Dendritic Cells at Steady State Authors: Seon Hyang Park, Yoe-Sik Bae Published: 2026 ABSTRACT The lung immune system is uniquely adapted to sustain continuous exposure to environmental stimuli while avoiding excessive inflammation. Among lung-resident immune cells, alveolar macrophages are well recognized as key regulators of immune quiescence and tissue homeostasis under steady-state conditions. In contrast, the roles of dendritic cells (DCs), another population of resident immune cells, have received comparatively less attention, likely owing to their lower abundance within the lung tissue. Nevertheless, as professional antigen-presenting cells and central orchestrators of adaptive immunity, DCs are critically positioned to determine the balance between immune tolerance and activation in the lung. Recent studies have increasingly highlighted the contribution of lung DCs to the pathogenesis of inflammatory and neoplastic lung diseases, including allergy, asthma, and cancer. However, how DCs are positioned, conditioned, and functionally regulated under steady-state conditions remains incompletely understood. In this review, we focus on spatial organization, cellular interactions, and microenvironmental cues that shape lung DC behavior at steady-state and delineate how these homeostatic programs preserve immune tolerance while maintaining immune readiness. INTRODUCTION The lung is a vital organ responsible for respiration and is essential for life. Because continuous gas exchange occurs, the lung is constantly exposed to a wide range of external environmental factors. The alveoli, where gas exchange takes place, possess a thin structure and a large surface area, rendering them highly vulnerable to infection and exposure to toxic substances. In addition, pulmonary capillaries are closely located to the alveolar wall and accommodate a high volume of blood flow, which is optimal for gas exchange but also allows for rapid infiltration of immune cells and easy dissemination of pathogens under infectious or inflammatory conditions (123). To counterbalance these risks, the diverse cell types that constitute the lung continuously perform appropriate defense mechanisms while tightly regulating excessive inflammatory responses to maintain tissue homeostasis. Fine-tuning of immune responses within the lung microenvironment involves coordinated interactions between lung epithelial cells and immune cells. Epithelial cells serve as the first line of physical defense against external insults and act as initial sensors for invading pathogens. Upon antigen recognition, epithelial cells secrete appropriate signaling molecules that alert resident immune cells within the lung (45). Immune cells in the lung can be activated either through signals derived from epithelial cells or through direct antigen recognition, and depending on the context, they may either promote or suppress inflammatory responses. Given the uniquely high frequency and intensity of exposure to external antigens compared with other organs, suppression of immune responses is essential in the lung. Consequently, the lung establishes and maintains an immune-tolerant environment. Alveolar macrophages, for example, exhibit attenuated TLR signaling, continuously secrete anti-inflammatory cytokines, and actively clear antigens, thereby suppressing dendritic cell (DC) activation and preventing the initiation of adaptive immunity (6). Conventional DCs (cDCs) residing in the lung also receive anti-inflammatory signals, transfer only limited amounts of antigen, and display a tendency to induce Treg cell differentiation. As a result, the lungs are intrinsically enriched in Treg cells with strong suppressive function (7). However, when immune tolerance is disrupted due to excessive inflammation or infection, DCs become activated, leading to the initiation of adaptive immune responses. This can result in persistent and chronic pulmonary inflammation and ultimately cause severe lung tissue damage. Activation of adaptive immunity may represent a key switch that reshapes the immune-tolerant environment of the lung, and DCs are central regulators capable of directly controlling this process. To date, alveolar macrophages have been recognized as the most abundant immune cell population in the lung and as potent first defenders, and their importance has therefore been heavily emphasized in many studies. Nevertheless, DCs are also resident innate immune cells within the lung, and their critical roles in the initial defense against external insults, antigen sensing, and activation of adaptive immune cells are increasingly being recognized. In this review, “steady-state” refers to the physiological condition in which the lung maintains immune tolerance and tissue homeostasis in the absence of overt infection, tissue injury, or uncontrolled inflammation. Nevertheless, because many mechanisms governing lung DC homeostasis become more apparent when disrupted, selected inflammatory or disease-associated studies are discussed where they provide mechanistic insight into how steady-state DC programs are destabilized, reprogrammed, or converted into pathogenic states. Collectively, emerging evidence suggests that lung DC homeostasis is regulated through at least 3 interconnected layers: intrinsic developmental and metabolic programming, tissue niche-derived conditioning, and dynamic crosstalk with structural and immune cells. These regulatory layers cooperate to maintain a tolerogenic baseline state while preserving the capacity for rapid immune activation upon environmental challenges. This review focuses on how lung DCs are programmed, spatially organized, and dynamically conditioned by the pulmonary microenvironment to sustain immune homeostasis at steady-state. LUNG DC ONTOGENY, DEVELOPMENTAL SIGNALING, AND TURNOVER DCs originate from bone marrow (BM)-derived progenitors that are continuously replenished throughout the life. The majority of lung cDCs arise from BM precursors through a stepwise differentiation process before seeding peripheral tissues. Within the BM hematopoietic stem cells give rise to lineage-restricted macrophage-DC progenitors, which subsequently differentiate into common DC progenitors. As the earliest committed DC progenitor population, common DC progenitors further develop into pre-DCs. These pre-DCs subsequently egress from the BM, enter the systemic circulation, and migrate to peripheral organs, where they undergo localized differentiation into mature DCs within specific tissue microenvironments (8). Similar to DCs in other tissues, the development and maintenance of lung DCs largely depend on Fms-like tyrosine kinase 3 ligand (Flt3L) (910). Notably, the level of Flt3L and its downstream signaling requirements may vary across organs, contributing to the tissue-specific regulation of DC development (11). In addition to Flt3L, GM-CSF has also been implicated in the regulation of lung DC differentiation. However, in adult mice, GM-CSF primarily promotes CD103 expression on cDC1s and is largely dispensable for their development (12). Importantly, signaling through the PI3Kγ-Akt-mTOR axis downstream of Flt3 is selectively required for lung DC expansion, underscoring a tissue-specific signaling dependency in pulmonary DC development (13). The developmental pathways of lung DC subsets are further shaped by lineage-defining transcription factors. Under homeostatic conditions, cDC1 differentiation depends on BATF3 and IRF8, whereas cDC2 development requires IRF4 (14). In contrast to cDCs, lung-resident plasmacytoid DCs (pDCs) complete their differentiation within the BM prior to migration to peripheral tissues (15). pDC development is critically driven by Flt3L and further supported by cytokines within the BM, including M-CSF, IL-7, and thrombopoietin. This process requires transcription factors such as IRF8 and STAT3. Following tissue migration, functional maturation of pDCs involves Runx2, whereas GM-CSF-STAT5 signaling has been reported to suppress pDC generation in an IRF8-dependent manner (16). Under steady-state conditions, lung DCs exhibit a comparatively lower turnover rate than DCs in many other tissues, and proliferation of mature DCs within the lung is relatively limited (17). Nevertheless, turnover kinetics vary depending on the specific subset and anatomical compartment. Airway-migratory DCs turn over rapidly every 2–3 days, whereas parenchymal CD11b+ and CD103+ DCs exhibit half-lives of approximately 2 and 4 weeks, respectively, and are maintained by continuous influx of BM-derived precursors (1819). Pre-DCs from BM egress into circulation and migrate to the lung, through coordinated chemokine receptor signaling. Notably, CXCR4 contributes to the retention of pre-DCs within the BM, whereas CCR2 and CX3CR1 promote their migration to the lung under steady-state conditions (20). METABOLIC PROGRAMMING AND TISSUE ADAPTATIONS DC subsets exhibit distinct metabolic programming that supports their differentiation, survival, and functional specialization. Under steady-state conditions, cDC1s display higher mitochondrial content and membrane potential than cDC2s, preferentially relying on oxidative phosphorylation and fatty acid oxidation (FAO). Conversely, cDC2s exhibit a greater dependence on glycolytic metabolism. The unique pulmonary microenvironment further modulates this metabolic wiring, thereby tailoring DC subset-specific function. Moreover, during Flt3L-driven DC differentiation and survival, cDC1s predominantly depend on the LKB1-AMPK-FAO axis. In contrast, cDC2s display metabolic features associated with ROS-dependent signaling, highlighting distinct metabolic requirements between these 2 cDC subsets (21). In particular, mTOR-dependent metabolic adaptation is essential for maintaining DC homeostasis in non-lymphoid tissues such as the lung. In CD11c-Cre mTORflox/flox mice, the CD103+ cDC population is markedly reduced, whereas the CD11b+ DC subset remains largely unaffected. This reduction in CD103+ cDCs is primarily attributed to increased apoptosis rather than deficiency in cellular proliferation or migration. These findings indicate that mTOR signaling supports the survival of CD103+ DCs through lung-specific metabolic adaptation (22). Together, these developmental and metabolic programs establish the foundation for lung DC homeostasis under steady-state conditions (Fig. 1). Developmental pathways of lung DC subsets under steady-state conditions. DCs originate from BM progenitors and undergo differentiation before populating peripheral tissues. In the BM, MDPs differentiate into CDPs, which give rise to pre-DCs that migrate to lung in a CCR2 and CX3CR1 dependent manner. pDCs can differentiate in the BM under the influence of cytokines such as Flt3L, M-CSF, IL-7, and thrombopoietin, requiring transcription factors including IRF8 and STAT3. After migrating to the lung, pDCs further mature through IRF8 and Runx2 dependent pathways, whereas STAT5 signaling can inhibit IRF8 mediated pDC maturation. In lung, pre-DCs differentiate into cDC1 or cDC2 under the influence of Flt3L and GM-CSF signaling. cDC1 differentiation requires the transcription factor BATF3 and IRF8, whereas cDC2 development is dependent on IRF4. In addition, cDC1 preferentially utilizes FAO and mTOR-dependent metabolic pathways, while cDC2s prefer a ROS-dependent metabolic pathway for their survival and differentiation (created in http://Biorender.com). MDP, macrophage-dendritic cell progenitor; CDP, common dendritic cell progenitor; pre-DC, dendritic cell precursor. DC SUBSETS IN THE LUNG AND THEIR ROLE IN IMMUNE TOLERANCE DCs are professional antigen-presenting cells that orchestrate both innate and adaptive immunity. Numerous studies have demonstrated that lung DCs play a critical role in regulating immune tolerance in the lungs, a unique organ continuously exposed to a wide range of environmental antigens. Within the pulmonary tissue, DCs are broadly classified into 3 major subsets: cDCs, pDCs, and monocyte-derived DCs (moDCs). Among these, cDCs represent the predominant resident DC population under homeostatic conditions, serving as central regulators of immune tolerance in this continuously antigen-exposed organ (232425). Lung cDCs are further subdivided into cDC1 and cDC2 subsets, each characterized by distinct localization patterns and specialized immunological functions. cDC1s The cDC1s subset is classically defined by the expression of CD103 and XCR1, with cells strategically positioned within or proximal to the airway and alveolar epithelium. This spatial localization enables the efficient sampling of epithelial-derived and inhaled luminal antigens. Although cDC1s are traditionally recognized for their proficiency in antigen cross-presentation and CD8+ T cell priming via the MHC class I pathway, accumulating evidence indicates their functional plasticity; for instance, during allergic inflammation, they can also contribute to Th2 and Th17 polarization (2627). Under homeostatic conditions, inhaled antigens prompt CD103+ cDC1s to upregulate aldehyde dehydrogenase 1a2, a critical enzyme for retinoic acid (RA) synthesis. This local metabolic programming drives the differentiation of naïve T cells into Treg cell, thereby actively contributing to the establishment of pulmonary immune tolerance (2829). Recent high-resolution single-cell transcriptomic analyses have challenged the traditional paradigm of a uniform cDC1 population, revealing substantial intra-subset heterogeneity within the steady-state lung, which can be further shaped by inflammatory or disease-associated cues (3031). Notably, a recent study identified 2 transcriptionally distinct Batf3+ Irf8+ cDC1 clusters that can be further distinguished based on Xcr1 expression, forming Xcr1− and Xcr1+ cDC1 populations (32). This finding contrasts with the conventional view that Xcr1 is a pan-cDC1 marker, demonstrating that phenotypic diversity exists even under steady-state conditions. Consistent with this heterogeneity, Xcr1+ cDC1s exhibit higher expression of genes associated with immune regulation, antigen presentation and T-cell activation, suggesting a more tolerogenic or immune regulatory phenotype. Conversely, Xcr1−cDC1s preferentially express inflammation-related genes. These transcriptional differences imply that distinct cDC1 subsets may be functionally specialized to support either immune tolerance or inflammatory immune responses depending on the local tissue environment, although direct functional validation remains limited. An important conceptual question remains as to whether these transcriptionally defined clusters represent stable, lineage-committed developmental sub-lineages or merely transient, context-dependent activation states shaped by the local microenvironment. Developmental stage further contributes to the heterogeneity of pulmonary cDC1 populations. During the first 2 weeks after birth, a CD103int DC subset emerges in the developing lung and draining lymph nodes. These cells require BATF3 for development but differ from CD103hi cDC1s by exhibiting higher expression of homing and co-stimulatory markers, including CCR7, PD-L1, and CD40, which correlates with enhanced efferocytosis and accelerated trafficking to regional lymph nodes. Unlike cDC1s, CD103int DCs show limited capacity to activate CD8+ T cells or induce Treg differentiation (33). This highlights that developmental age profoundly shapes the baseline tolerogenic versus immunogenic programming of pulmonary cDC1 lineages. cDC2s In contrast to cDC1s, cDC2s are typically defined by CD11b expression and are preferentially enriched within the lamina propria. At steady-state, cDC2s exhibit substantial functional heterogeneity, with recent single-cell studies identifying distinct subsets specialized for maintaining pulmonary immune homeostasis. Although cDC2s have historically been recognized for directing CD4+ T helper cell differentiation during inflammation, accumulating evidence indicates that specific cDC2 populations also play essential roles in sustaining immune tolerance. Under homeostatic conditions, the IFNAR1hi TNFR2+ cDC2 subset, designated as iR2D2, exhibits a distinct tolerogenic phenotype specialized for promoting pulmonary Treg differentiation and preserving respiratory immune tolerance. This subset is characterized by elevated expression of inhibitory and regulatory molecules such as PD-L1, PD-L2, Arg-1, and BTLA. Mechanistically, epithelial cell-derived IFNβ activates IFNAR1 signaling in these cells, inducing TGF-β1 production. This epithelial-driven signaling reinforces their capacity to drive Treg differentiation, contributing to the maintenance of pulmonary immune homeostasis. In contrast, during allergic inflammation, these cells undergo phenotypic and functional reprogramming toward an inflammatory DC state (34). In the GM-CSF-rich environment of the lung, CD301b+ cDC2s represent another homeostatic cDC2 population that contributes to pulmonary immune tolerance through TGF-β1-mediated Treg differentiation (3031). Together, these findings indicate that pulmonary cDC2s comprise functionally distinct subsets that support immune homeostasis at steady state but can undergo inflammatory reprogramming in response to changes in the local tissue environment. Collectively, these observations highlight that much of the currently recognized heterogeneity within lung cDC1 and cDC2 populations has been revealed through transcriptomic analyses, and many newly identified subsets still require functional validation. Moreover, because DC phenotypes vary according to developmental stage, tissue context, inflammatory conditions, and species, careful interpretation of subset classification and nomenclature remains essential. Table 1 summarizes the currently recognized steady-state lung cDC1 and cDC2 subsets identified in mice and their representative characteristics. Table 1Lung cDC subsets in steady statesLung cDCRepresentative markers/TFsSubsetCharacteristicsRef.cDC1Batf3+, IRF8+Xcr1− DC1- Higher expression of inflammation related genes(32)Xcr1+ cDC1- Higher expression of immune regulatory, antigen presentation, and T cell activation-related genesCD103int cDC1 (neonatal lung)- Higher expression of CCR7, PD-L1, CD40(33)- Enhanced efferocytosis and migration to lymph nodesCD103hi XCR1+cDC1- Activation of CD8+ T cells and Treg differentiationcDC2CD11b+, IRF4+IFNAR1hi TNFR2+ cDC2- Promoting Treg differentiation(34)- Elevated expression of inhibitory and regulatory molecules (PD-L1, PD-L2, Arg-1, BTLA)CD301b+ cDC2- Non-migratory subset promoting Treg differentiation through TGF-β1(30)TF, transcription factor. Lung cDC subsets in steady states TF, transcription factor. pDCs and moDCs pDCs-phenotypically identified by PDCA-1, B220 and Siglec-H expression-constitute a minor fraction of the resident DC pool in the steady-state lung. While globally recognized for their potent antiviral effector functions during infection, including robust type I interferon production and CD8+ T cell priming (35), pDCs also play an active, non-redundant role in maintaining baseline mucosal tolerance. Notably, experimental depletion of pDCs under steady-state converts normal tolerance toward harmless antigens into robust, Th2-driven allergic inflammation. Conversely, the adoptive transfer of antigen-pulsed pDCs into established asthma models effectively suppresses eosinophilia and Th2 cytokine production (36), underscoring the role of the steady-state pDC niche as a critical immunological damper against inappropriate allergic sensitization. In contrast to these resident lineages, moDCs are virtually absent in the healthy, uninflamed lung parenchyma. They are generated from circulating monocytes exclusively during acute infection or severe tissue injury. Because moDCs are evolutionarily wired to maximize inflammatory effector responses rather than maintain immunological homeostasis, they fall outside the core homeostatic resident DC pool and serve primarily as cellular hallmarks of steady-state disruption. KEY MECHANISMS OF IMMUNE CONTROL Beyond subset-specific specialization, pulmonary immune tolerance also depends on intrinsic regulatory mechanisms that maintain the homeostatic function of resident DCs. These mechanisms enable lung DCs to integrate local environmental signals while preserving immune quiescence under steady-state conditions. The absolute requirement for these intrinsic pathways is demonstrated by DC-specific IL-10 receptor-deficient mice. Conditional ablation of IL-10 receptor signaling in DCs abrogated tolerance induction, resulting in severe neutrophilic inflammation, airway hyperreactivity, and enhanced Th2 cytokine production upon antigen challenge. In contrast, deletion of the IL-10 receptor in T cells, B cells, monocytes/macrophages, or neutrophils has no effect, underscoring the DC-intrinsic requirement for IL-10 signaling in maintaining lung immune tolerance (37). This selective susceptibility demonstrates the strict requirement for continuous IL-10 signaling within lung DCs to maintain steady-state pulmonary tolerance. Recent studies employing intranasal immunization with peptide antigens conjugated to nanofibers have further expanded this view by demonstrating that CD8+ T cells can be cross-primed directly within the lung prior to antigen drainage to the mediastinal lymph nodes. These findings challenge the traditional paradigm that T cell priming is strictly lymph node-dependent and underscore the capacity of lung-resident DCs to directly regulate local T cell immunity, thereby reinforcing their role in maintaining tissue-level immune balance (38). DCs also critically influence humoral immune responses in the lung. Following the resolution of respiratory insults, the lung often retains tertiary lymphoid organs known as inducible bronchus-associated lymphoid tissue (iBALT). Although initially induced during active inflammation (such as influenza virus infection), iBALT serves as a specialized tissue-organized niche that supports T and B cell proliferation as well as germinal immunoglobulin class switching (39). Beyond their role during active infection, lung-resident DCs are critical structural determinants for the post-inflammatory maintenance of iBALT. Selective depletion of lung DCs after viral clearance results in the rapid disruption of iBALT structures and subsequently impairs systemic humoral responses. These findings demonstrate that lung-resident DCs are indispensable not only for maintaining these tertiary lymphoid structures but also for sustaining humoral immunity (40). Collectively, these observations highlight that pulmonary immune tolerance is maintained through continuous interactions between resident DCs and their surrounding tissue microenvironment rather than by passive immune quiescence alone. Cell-intrinsic regulatory pathways, local antigen presentation, and tissue-organized immune niches together enable lung DCs to sustain immune homeostasis while preserving functional adaptability. Defining how these regulatory programs are instructed by lung-derived soluble mediators and anatomical niches represents an important next step toward understanding pulmonary immune homeostasis. LUNG-DERIVED SOLUBLE FACTORS AS DYNAMIC REGULATORS OF DC FUNCTION The pulmonary environment must continuously defend against airborne antigens while meticulously maintaining a tightly controlled immunological threshold to preserve tissue integrity and efficient gas exchange. Operating at the nexus of this delicate balance, lung DCs are profoundly governed by a diverse array of soluble factors-including growth factors, cytokines, and chemokines-secreted by epithelial cells, stromal cells, endothelial cells, and immune cells, as well as from DCs themselves (4142434445). Rather than functioning as simple binary on-off switches, these microenvironmental mediators dynamically shape DC differentiation, survival, activation thresholds, migratory capacity, and T cell-polarizing functions in a context-, subset-, and time-dependent manner (4142434445). GM-CSF GM-CSF represents a paradigmatic example of a factor that exerts pleiotropic and context-dependent effects on DC biology. GM-CSF is produced by multiple pulmonary cell types, including airway epithelial cells (AECs), and is markedly elevated during infection, inflammation, and allergic disease (4647). Under steady-state conditions, GM-CSF is required for the differentiation, maturation, and survival of CD103+ cDC1s, thereby supporting efficient CD8+ T cell immunity (48). Recent lung-specific landscapes have revealed that GM-CSF, specifically derived from alveolar type 2 epithelial cells, is essentially required for the generation and maintenance of CD301b+SIRPα+ cDC2s. Mechanistically, GM-CSF promotes anti-apoptotic gene expression programs in these cDC2 subsets, thereby sustaining their survival and functional specialization (31). At the steady-state, CD301b+ cDC2s preferentially induce allergen-specific CD25+Foxp3+ Treg cells, reinforcing local mucosal tolerance (30). The true functional plasticity of the GM-CSF-DC axis is illuminated when homeostasis is disrupted. Analyzing infectious and inflammatory disease models provides vital mechanistic insights into how this identical signaling pathway can be subverted or redirected toward immunogenic and pathogenic programs. Upon exposure to allergenic stimuli such as house dust mite extract, a substantial fraction of the otherwise tolerogenic CD301b+ cDC2s population undergoes dramatic phenotypic reprogramming, transitioning into a mature, Th2-inducing state. The homeostatic balance between tolerogenic and immunogenic cDC2 states is finely gated by GM-CSF signaling. This regulatory rheostat is evidenced by the fact that disruption of GM-CSF receptor signaling selectively in cDCs severely depletes the pool of Treg-inducing CD301b+ cDC2s, which subsequently accelerates aberrant, Th2-driven immune responses (30). These observations highlight the context-dependent nature of GM-CSF signaling in lung DC biology. While GM-CSF plays an indispensable role in maintaining resident DC subsets and supporting tolerogenic immune regulation under steady-state conditions, alterations in the local inflammatory environment can substantially reshape its downstream functional outputs. Therefore, investigating GM-CSF within infectious and inflammatory settings provides critical mechanistic insights into how a conserved signaling pathway can be redirected toward immunogenic programs when lung homeostasis is disrupted. During acute infectious or inflammatory challenges, GM-CSF shifts from a homeostatic survival factor to a potent driver of DC activation and adaptive immunity. For instance, early studies utilizing adenoviral-mediated expression demonstrated that sustained local production of GM-CSF promotes the differentiation and activation of pulmonary myeloid DC populations, a process amplified through indirect macrophage-mediated inflammatory network during immune responses to viral infection (49). Similarly, during influenza virus infection, GM-CSF-dependent crosstalk between influenza virus-infected alveolar epithelial cells and CD103+ DCs is crucial for effective viral clearance and tissue repair (50); baseline GM-CSF is required for the parenchymal persistence of these cDC1s, while infection-induced upregulation of the cytokine ensures their robust activation and subsequent trafficking to draining mediastinal lymph nodes. Conversely, during bacterial infection or inflammatory conditions dominated by moDCs or inflammatory DCs, GM-CSF is largely dispensable for DC maturation and function, underscoring the stimulus- and subset-specific nature of GM-CSF signaling (48). In chronic inflammatory disease, GM-CSF further amplifies pathology by establishing a DC-T cell inflammatory circuit. In models of steroid-resistant asthma, although GM-CSF is not intrinsically required for neutrophil migration, it heavily upregulates lung DC antigen uptake, lymph node transport, and T cell priming, thereby promoting T cell-dependent recruitment of neutrophils and mixed Th2/Th17 immune responses (51). Taken together, these findings suggest that GM-CSF does not function as a rigid, intrinsically tolerogenic or inflammatory mediator. Instead, it operates as a sophisticated microenvironmental rheostat that orchestrates distinct, tailored DC programs according to the underlying tissue state, cellular targets, and microenvironmental cues. IFNβ IFNβ is a key type I cytokine that exerts dual, context-dependent effects on DC biology, balancing acute activation with the preservation of tissue homeostasis. While type I IFNs, including IFNβ, traditionally enhance MHC class II expression, antigen uptake, and presentation capacity during infection, they concurrently serve as homeostatic dampers that limit excessive inflammation and enforce a tolerogenic phenotype in resident DCs (52). Under steady-state conditions in the lung, epithelial cells serve as an important source of IFNβ. Through intrinsic IFNAR1 signaling, epithelium-derived IFNβ activates the ERK2-FAO axis in TNFR2+ cDC2s, thereby promoting Treg differentiation and maintaining immune tolerance (35). The therapeutic relevance of this homeostatic axis is further illustrated in house dust mite-induced asthma models, where exogenous IFNβ administration successfully redirects TNFR2+ cDC2s back toward a tolerogenic state (52). These findings from inflammatory models reinforce the concept that steady-state epithelial-DC crosstalk is dynamically wired to preserve pulmonary immune homeostasis, and disrupting this baseline IFNβ signaling primes the mucosal environment for pathogenic allergic hypersensitivity. TGF-β TGF-β is a multifunctional cytokine that serves as a cornerstone of immune regulation, tissue remodeling, and fibroproliferative cascades in the pulmonary environment. While pathologically elevated levels of active TGF-β are a hallmark of fibrotic lung diseases-such as idiopathic pulmonary fibrosis, where they drive excessive extracellular matrix deposition and myofibroblast accumulation (53), baseline TGF-β signaling represents a non-redundant environmental cue under steady-state conditions. Within the homeostatic tissue niche, TGF-β exerts complex effects on DC biology: it promotes early DC progenitor development while potently suppressing the premature activation and maturation of immature resident DCs. In both human and murine systems, baseline TGF-β restricts DC-mediated T cell stimulation by inhibiting the upregulation of costimulatory molecules, including CD80, CD83, and CD86 (54), thereby maintaining a high activation threshold during harmless antigen exposure. A principal mechanism by which TGF-β shapes tissue-adapted, tolerogenic DC phenotypes is through the induction of CD103 expression, a key marker for the mucosal cDC1 lineage. The critical requirement for this pathway is demonstrated by analyzing its subversion in experimental disease models. In bleomycin-induced pulmonary fibrosis models, severe tissue injury disrupts homeostatic epithelial-stromal networks, altering both the accumulation and phenotypic maturation of CD11c+ lung DCs. Pharmacological inhibition of TGF-β signaling in these models significantly attenuates cDC accumulation after bleomycin-induced damage, indicating that TGF-β is a key determinant of DC dynamics and kinetic reprogramming during fibrotic remodeling (55). Beyond regulating local mucosal compartments, TGF-β-conditioned lung DCs participate in a broader, inter-organ immune crosstalk. Resident lung DCs possess the unique capacity to imprint gut-homing receptors, including α4β7 integrin and CCR9, on interacting T cells, thereby licensing their migration to the gastrointestinal tract and conferring protection against intestinal pathogens. Mechanistically, lung-derived TGF-β acts in concert with RA to endow lung DCs with tissue-imprinting capacity (55). This inter-mucosal axis illustrates how localized, niche-derived soluble factors can orchestrate broader systemic immune connectivity and cross-tissue protection. RA RA, a potent immunoregulatory metabolite derived from vitamin A, is abundantly produced at mucosal barriers, including the lung. Under steady-state conditions, RA acts as a critical molecular conduit that integrates localized epithelial and stromal cues to actively orchestrate tolerogenic DC programming (5657). In vitro mechanistic studies demonstrate that RA treatment enhances the expression of tolerogenic markers-such as CD141 and GARP-on DCs, significantly increasing their capacity to induce Foxp3+ Tregs and thereby supporting airway immune homeostasis (58). Intriguingly, while RA classically reinforces DC tolerogenicity during steady-state homeostasis, analyzing its role during infectious challenges reveals the stark context-dependency of this pathway. For instance, Farazuddin et al. (59) paradoxically reported that RA signaling suppresses DC antiviral responses during RSV infection. This striking contrast in infectious settings highlights that the immunomodulatory effects of RA are not fixed, but are instead dynamically redirected by the overarching microenvironmental context, illustrating how a homeostatic damping mechanism can inadvertently compromise host defense during acute viral insults. VEGF VEGF, while classically defined by its canonical orchestrating role in angiogenesis, serves as a potent immunomodulatory mediator that actively reshapes the functional landscape of lung DCs. The physiological significance of the VEGF-DC axis becomes most striking when homeostatic boundaries are breached. Transgenic overexpression of VEGF within the murine lung dramatically increases both the number and activation state of cDCs and pDCs, characterized by markedly increased expression of MHC class II and costimulatory molecules. Functionally, these VEGF-conditioned DCs exhibit increased antigen uptake and enhanced migration to draining lymph nodes. At the molecular level, VEGF drives cDCs toward an inflammatory and tissue-remodeling phenotype-a programmatic shift governed by preferential VEGFR2 signaling and characterized by upregulation of matrix-degrading enzymes, inflammatory chemokines that favor a pathologically biased, Th2-skewed cytokine milieu (60). However, under steady-state conditions, basal levels of VEGF act as a vital homeostatic anchor and are essential for maintaining capillary vascular integrity and supporting alveolar epithelial cell survival. This microenvironment may indirectly dictate the spatial localization, compartmental density, and architectural positioning of resident lung DCs (61). However, the precise molecular networks linking homeostatic VEGF signaling to the baseline regulation of DC subsets in the steady-state lung remain to be further elucidated. Prostaglandin E2 (PGE2) PGE2, a bioactive lipid mediator abundantly produced by lung epithelial cells and stromal cells, plays a crucial role in pulmonary vascular remodeling and allergic airway inflammation. The protective value of baseline PGE2 signaling is clearly demonstrated by genetic deficiencies in the lung, which dramatically heighten susceptibility to airway hyperresponsiveness upon exposure to allergy-inducing molecules (62). At the cellular level, PGE2 exerts complex, context-dependent immunoregulatory effects on resident lung DCs. Mechanistically, PGE2 signaling primes DCs by upregulating CCR7-dependent trafficking machinery to facilitate their migration to draining lymph nodes, while simultaneously restraining excessive inflammatory cytokine production, thereby contributing to context-dependent immune regulation (6364). However, the mechanisms through which niche-derived PGE2 dampens resident DC maturation under steady-state conditions remain undefined. Alarmins TSLP is a cardinal epithelium-derived alarmin that plays a central role in initiating type 2 immune responses at barrier tissues. The pathological relevance of the TSLP-DC axis is illustrated in the context of disrupted tissue homeostasis; TSLP expression is markedly elevated in the airway of asthmatic patients, and experimental models of allergic hypersensitivity demonstrate that localized TSLP signaling is sufficient to induce type 2 airway inflammation (65). Mechanistically, TSLP acts as a critical upstream signal that translates epithelial stress or injury into DC-mediated adaptive immune polarization. It directly activates and conditions resident DC populations, specifically cDC2 lineage-reprogramming them to acquire an enhanced costimulatory capacity that preferentially drives CD4+ T cell differentiation toward a Th2 phenotype. These findings highlight how epithelial-derived soluble factors selectively instruct DC subsets to promote allergic inflammation in the lung (66). However, in vivo data on the lung under steady-state conditions remain limited. In addition to TSLP, the epithelial-derived alarmins IL-33 and IL-25 further act in concert to shape DC-dependent type 2 immunity by enhancing DC–group 2 innate lymphoid cell (ILC2) and DC-Th2 interactions during allergic airway inflammation (6768). Although the effects of IL-33 and IL-25 on lung DCs have been primarily investigated in allergic settings, emerging evidence suggests that basal alarmin signaling may contribute to the calibration of resident DC function and immune readiness under steady-state conditions. Consequently, dissecting these inflammatory networks provides vital insights into how disrupted alarmin thresholds compromise tissue balance. Further precise investigations are required to define the exact molecular mechanisms governing these epithelial pathways during lung DC homeostasis. The major lung-derived soluble factors regulating pulmonary DC function under homeostatic and inflammatory conditions are summarized in Table 2. Table 2Lung-derived soluble factors shaping DC function under homeostatic and inflammatory conditionsLung-derived soluble factorMajor cellular sourcesDC subsets affectedEffects on DCFunctional outcomeGM-CSFAECs, AT2 cells, immune cellsCD103+ cDC1, CD301b+SIRPα+cDC2Promotes DC differentiation, survival, activation, and migration in a context- and subset-dependent manner- Homeostasis: supports cDC1 survival and CD8+ T cell immunity, maintains Treg-inducing CD301b+ cDC2s- Allergy: imbalance favors Th2 polarization and steroid-resistant asthma- Infection: enables CD103+ DC migration to mLNs and antiviral immunityIFNβAECsIFNARhiTNFR2+cDC2Activates intrinsic IFNAR1-ERK2-FAO signaling, promoting TGF-β1 production and tolerogenic programming- Homeostasis: promotes Treg differentiation and maintains pulmonary immune tolerance through epithelial-DC crosstalk- Allergy: exogenous IFNβ restores the tolerogenic phenotype of TNFR2+cDC2s and suppresses allergic airway inflammationTGF-βEpithelial cells, fibroblasts, immune cellsCD103+ DCsSupports early DC development while suppressing maturation and costimulatory molecule expression- Homeostasis: promotes tolerogenic DC phenotypes- Fibrosis: regulates DC accumulation and phenotype during lung remodeling- Mucosal crosstalk: cooperates with RA to imprint gut-homing properties on T cellsRAEpithelial cells, stromal cellscDCsEnhances tolerogenic programming and Treg induction, context-dependent suppression of antiviral DC responses- Homeostasis: promotes Treg differentiation and airway tolerance- Viral infection (RSV): dampens DC antiviral immunityVEGFEpithelial cells, endothelial cellsmDCs, pDCsEnhances DC accumulation, activation, antigen uptake, and LN migration, induces inflammatory gene programs- Homeostasis: may influence the localization and density of lung DCs- Pathology: promotes Th2-skewed immunity, airway inflammation, and tissue remodelingPGE2 Epithelial cells, stromal cellsResident lung DCsEnhances CCR7-dependent migration while limiting inflammatory cytokine production- Homeostasis: maintains immune balance (mechanism remains unclear)- Allergy: deficiency increases airway hyperresponsivenessTSLPAECscDC2Conditions DCs to preferentially induce Th2 differentiation- Homeostasis: physiological role in steady-state DC regulation remains incompletely defined- Allergy: initiates type 2 airway inflammation and allergic asthma via epithelial-DC axisIL-33/IL-25Epithelial cellscDC2Amplifies DC-ILC2 and DC-Th2 interactions- Homeostasis: may contribute to basal epithelial-immune communication, although direct effects on resident DCs remain incompletely defined- Allergy: reinforces type 2 immune circuits in allergic airway inflammationmLN, mediastinal lymph node; RSV, respiratory syncytial virus. Lung-derived soluble factors shaping DC function under homeostatic and inflammatory conditions mLN, mediastinal lymph node; RSV, respiratory syncytial virus. CELLULAR INTERACTIVITY AND NICHES GOVERNING LUNG DC HOMEOSTASIS To preserve pulmonary tissue integrity and unhindered gas exchange, structural components such as respiratory epithelial cells and stromal fibroblasts function not merely as passive physical barriers, but as active immunoregulatory hubs (469). These structural cells continuously sense environmental inputs and secrete a vast repertoire of soluble mediators-including growth factors, cytokines, and chemokines- that fine-tune leukocyte behavior and modulate the local immune microenvironment (568). Under inflammatory conditions, epithelial cells and fibroblasts upregulate chemokines that drive the recruitment of neutrophils, monocytes, eosinophils, and other leukocytes into the lung. In addition, damage-associated molecular patterns released from injured structural cells are sensed by pattern-recognition receptors and further activate or modulate immune responses. Epithelial-DC dynamics Lung DCs reside in close physical apposition to AECs, enabling a continuous, bidirectional communication axis that is critical for maintaining mucosal equilibrium (7071). This proximity profoundly shapes DC phenotypes and their capacity to orchestrate local immune responses. The physiological importance of this architectural arrangement is clearly demonstrated by homeostatic disruption; in a 3-dimensional human lung mucosa model, epithelial dysfunction drives excessive DC activation through the dysregulated production of the Th2-attracting chemokines CCL17, CCL18, and CCL22 (72). Despite the generally immunosuppressive nature of the pulmonary environment, DCs retain the capacity to respond to pathogens and support tissue protection. AECs secrete tolerogenic factors such as RA, which promote DC tolerance under homeostatic conditions. However, co-culture studies have revealed that AECs can simultaneously enhance the immunogenic potential of DCs. DCs conditioned by AECs exhibit transcriptional reprogramming characterized by upregulation of chemokines involved in neutrophil and NKT cell recruitment, increased expression of MHC class II molecules, and enhanced expression and functional activity of pattern recognition receptors, including TLRs and NOD-like receptors, along with their downstream signaling pathways (73). These findings indicate that epithelial-DC interactions do not simply enforce immune suppression but instead calibrate DC responsiveness to preserve immune readiness within a tolerogenic environment. Stromal-DC networks Beyond epithelial-DC interactions, pulmonary stromal cells, of which fibroblasts constitute a major component, have emerged as important modulators of DC phenotype and function, particularly in the context of immune tolerance. To elucidate the role of pulmonary stromal cells in shaping the lung microenvironment and maintaining immune tolerance, murine pulmonary stromal cells (MPSCs) have been used in co-culture systems with immature DCs. Upon MPSC encounter, immature DCs acquire a regulatory phenotype characterized by suppressed T cell-stimulatory capacity, inhibition of T cell proliferation, and enhanced induction of Tregs. Importantly, this stromal cell-driven regulatory programming of DCs is largely dependent on soluble factors produced by MPSCs, particularly TGF-β (69). Consistent with these findings, earlier in vitro studies further demonstrated that human lung fibroblasts can modulate DC phenotype toward a less mature state through both direct cell-cell contact and soluble mediators, suggesting that fibroblast-DC interactions may sustain chronic inflammation and immune dysregulation in fibrotic lungs (74). More recently, a pathogenic extension of this stromal-DC crosstalk has been identified in pulmonary fibrosis. A population of aryl hydrocarbon receptor-expressing tissue-resident DCs responds to kynurenine produced by TDO2-expressing myofibroblasts, leading to DC activation via non-canonical aryl hydrocarbon receptor signaling in a CD4+ T cell-independent manner and promoting fibrotic remodeling of the lung (75). Macrophage-DC network In addition to structural cells, interactions between DCs and other pulmonary phagocytes are critical for immune homeostasis. Among these, alveolar macrophages represent a well-established population of lung-resident immune cells that actively preserve tissue homeostasis through continuous interactions with neighboring cells, including DCs (176). Through these interactions, alveolar macrophages can modulate the activation state of lung DCs, thereby shaping local immune responses (77). Under homeostatic conditions, alveolar macrophages predominantly suppress DC activation to prevent unnecessary immune responses against harmless inhaled antigens (787980). Spatial mapping studies have revealed that, under steady-state conditions, alveolar macrophages are largely confined to the alveolar lumen and engage in minimal direct cell-cell contact. In contrast, interstitial macrophages 2, CD11b+ DCs, and CD103+ DCs form organized clusters within peri-bronchial and perivascular regions, while pDCs preferentially localize to vessel-adjacent interstitial niches. Notably, frequent direct contact between interstitial macrophages 2 and CD103+ DCs is observed at baseline, supporting the existence of a tolerogenic crosstalk that contributes to immune quiescence. Disruption of this interaction following allergen exposure, such as house dust mite sensitization, coincides with increased DC accumulation and immune activation around the airways (81). Importantly, this crosstalk is bidirectional. DCs also play a critical role in maintaining alveolar macrophage homeostasis. Adenosine deaminases acting on RNA 1, expressed in DCs, are required for the development of CD103+/CD8+ DC subsets, and DC-specific adenosine deaminases acting on double-stranded RNA deficiency leads to depletion and functional impairment of alveolar macrophages, resulting in pulmonary alveolar proteinosis. Together, these findings underscore that pulmonary immune homeostasis is sustained through coordinated and reciprocal interactions between DCs and other resident phagocytes, in addition to cues derived from epithelial and stromal cells (82). Lymphocyte-DC axis Treg cells also participate in this cellular network by reciprocally reinforcing tolerogenic DC states in the lung. Although lung DCs promote Treg differentiation under steady-state conditions, Tregs can in turn restrain DC maturation and inflammatory cytokine production through suppressive cytokines, including IL-10, TGF-β, and IL-35, as well as CTLA-4-dependent modulation of CD80/CD86-mediated costimulatory signals (73783). In experimental allergic airway inflammation, CD4+CD25+ Tregs have been shown to alter pulmonary DC phenotype and function, supporting the concept that Tregs can directly calibrate DC immunogenicity in the lung (84). Thus, DC–Treg interactions should be viewed not only as a unidirectional pathway of Treg induction but also as a reciprocal feedback loop that stabilizes tolerogenic DC programming and limits inappropriate adaptive immune activation. ILC2s may provide an additional layer of homeostatic and context-dependent regulation of lung DC function. ILC2s are enriched among tissue-resident ILC populations in the steady-state lung and are positioned to rapidly sense epithelial-derived signals such as IL-25, IL-33, and TSLP (85). Although DC–ILC2 crosstalk has been most clearly demonstrated during allergic inflammation, where ILC2-derived IL-13 or GM-CSF can promote DC activation, migration, and Th2-priming capacity, these findings suggest that resident ILC2s may also contribute to basal type 2 immune tone and tissue repair-associated immune calibration (8687). Therefore, steady-state DC–ILC2 communication may contribute to the maintenance of pulmonary immune homeostasis. Further studies are needed to define how these interactions regulate resident DC function and influence immune balance under physiological conditions. Collectively, these multifaceted interactions among DCs, epithelial cells, fibroblasts, alveolar macrophages, and resident lymphoid populations establish lung DCs as central cellular integrators of microenvironmental tissue signals. By continuously balancing tolerogenic signals with immunogenic priming, this complex cellular network ensures that lung DCs fine-tune their functional programming to preserve pulmonary immune homeostasis at steady-state (Fig. 2). Cellular interactions shaping DC function in lung homeostasis. Under steady-state conditions, lung DCs are continuously conditioned by signals derived from structural and immune cells within the pulmonary microenvironment. AECs contribute to the maintenance of tolerogenic DC programs and immune readiness through the production of mediators such as RA, GM-CSF, and IFNβ. Interstitial fibroblasts provide TGF-β, which supports the differentiation and maintenance of tolerogenic DC subsets. AMs and IMs further contribute to DC regulation through reciprocal cellular interactions that promote immune homeostasis. Both CD103+ and CD11b+ DC populations can induce Tregs, whereas Tregs provide reciprocal feedback signals through suppressive mediators, including IL-10 and TGF-β, thereby reinforcing tolerogenic DC programming. Emerging evidence also suggests potential interactions between resident ILC2s and lung DCs under homeostatic conditions; however, the mechanisms and functional consequences of these interactions remain incompletely defined. Question marks indicate putative or incompletely characterized steady-state DC–ILC2 interactions whose mechanisms and functional consequences remain to be defined (created in http://Biorender.com). AM, alveolar macrophage; IM, interstitial macrophage. OUTSTANDING QUESTIONS AND FUTURE PERSPECTIVES While substantial progress has been made in defining the developmental pathways and functional specialization of lung DCs, several fundamental questions regarding their microenvironmental regulation remain unresolved. Moving the field forward will require addressing several critical areas that bridge homeostatic niches with pathological transitions. A primary challenge lies in precisely delineating the molecular and phenotypic boundaries of a truly homeostatic lung DC state. Recent advances in single-cell transcriptomics have revealed remarkable heterogeneity among lung DC populations, leading to the identification of multiple transcriptionally distinct subsets. However, it remains unclear whether these populations represent stable lineage-defined DC subsets, transient activation states, or environmentally induced functional adaptations. Resolving this issue will require integration of single-cell and spatial multi-omics approaches with fate-mapping strategies and in vivo functional validation. Furthermore, it remains to be determined how distinctive anatomical niches within the lung spatially dictate DC function under steady-state conditions. Emerging evidence suggests that epithelial cells, fibroblasts, alveolar macrophages, interstitial macrophages, Treg cells, ILC2, and other tissue-resident immune populations collectively contribute to the establishment of tolerogenic DC programs. However, the relative contribution of each cellular component and the mechanisms by which these signals are integrated within distinct microanatomical niches remain incompletely understood. Future studies employing spatial transcriptomics, multiplex imaging, and niche-specific perturbation strategies will likely provide important insight into these regulatory networks. Concurrently, capturing how environmental and host-derived factors reshape lung DC homeostasis over time remains a vital frontier. Aging, chronic inflammatory conditions, prior respiratory infections, environmental exposures, and microbiota-derived signals may all influence the composition and functional state of resident DC populations. Understanding how these factors alter steady-state DC programming may help explain individual differences in susceptibility to allergic, infectious, fibrotic, and neoplastic lung diseases. In addition, much of our current understanding of lung DC biology is derived from murine studies. Although recent human lung single-cell atlases have begun to reveal conserved and species-specific DC populations, the extent to which regulatory mechanisms identified in mice operate in human lungs remains unclear. Direct cross-species comparisons will therefore be essential for translating experimental findings into clinically relevant knowledge. Ultimately, a granular understanding of the mechanisms governing the maintenance or disruption of lung DC homeostasis will pave the way for novel immunotherapeutic interventions. Manipulating tolerogenic DC programs could potentially promote immune tolerance in allergic and inflammatory lung diseases, whereas selectively enhancing immunogenic DC functions may improve host defense against infection and augment antitumor immunity. Thus, elucidating the molecular and cellular principles governing lung DC homeostasis is likely to have broad implications for both fundamental immunology and translational medicine. Collectively, the evidence discussed throughout this review suggests that lung DC homeostasis cannot be fully explained by any single mechanism. Rather, it emerges from a multi-layered regulatory network integrated across 3 distinct dimensions: intrinsic developmental and metabolic programming, tissue niche-derived conditioning, and dynamic crosstalk with structural and immune cells. This coordinated framework conceptualizes how lung DCs orchestrate the delicate balance between maintaining tissue tolerance and preserving immediate immune readiness at steady state. The first layer, developmental/metabolic programming, encompasses core lineage-specifying transcription factors, metabolic fitness or bioenergetics, and epigenetic regulation such as chromatin accessibility and epigenetic marks that collectively establish the baseline functional poise of immature DCs. The second layer involves tissue niche-derived conditioning, wherein localized niche-derived mediators-including GM-CSF, TGF-β, RA, and alarmins-impart specific biochemical conditioning that shapes DC identity. The third layer comprises dynamic crosstalk with structural and immune cells, representing an intricate local network where DCs continuously exchange bidirectional signals with epithelial cells, fibroblasts, macrophages, Tregs, and ILC2s (Fig. 3). Ultimately, it is the homeostatic integration of these 3 regulatory layers-rather than any single isolated signal-that continuously programs lung DCs, enabling them to actively suppress unwarranted inflammation against innocuous antigens while remaining perpetually primed for rapid activation upon pathogen encounter. This framework may also provide a foundation for future studies aimed at elucidating how these regulatory layers interact across distinct tissue microenvironments. A conceptual 3-layer framework for lung DC homeostasis. A conceptual model proposing that lung DC homeostasis is established and maintained through the integration of 3 interconnected regulatory layers: 1) intrinsic developmental and metabolic programming, 2) tissue niche-derived conditioning, and 3) dynamic crosstalk with structural and immune cells (created in http://Biorender.com). CONCLUSION Lung DCs are strategically poised at the interface of barrier surveillance, uniquely programmed to sustain strict immune tolerance at baseline while maintaining acute responsiveness to invading pathogens. Distinct from alveolar macrophages, lung DCs serve as the non-redundant cellular bridge directly dictating T cell fate, positioning them as central regulators of adaptive immunity required to preserve pulmonary homeostasis. Historically, progress in understanding lung DC biology has been constrained by their sparse abundance and technical limitations, leading the field to focus predominantly on inflammatory or migratory moDCs observed under disease conditions. In this review, we have refocused the lens on lung-resident DCs, highlighting how their baseline programming is actively tuned by the lung microenvironment. Accumulating evidence demonstrates that, far from being intrinsically inert, lung DCs are continuously restrained through a tightly coordinated cellular network comprising epithelial cells, fibroblasts, alveolar macrophages, and lymphocytes. Crucially, this homeostatic restraint is not a state of passive suppression, but rather a highly plastic equilibrium that enforces immune readiness. Upon pathogen encounter or tissue barrier breach, this finely tuned threshold allows lung DCs to rapidly redirect their functional programs toward robust immunogenicity. Systematically elucidating these niche-specific calibration thresholds is essential for a deeper understanding of pulmonary immune homeostasis, providing a foundational conceptual framework to guide targeted therapeutic modulation across a broad spectrum of mucosal pathologies.